• 1. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 2. Excellent peroxidase mimicking property of CuO/Pt nanocomposites and their application as an ascorbic acid sensor?
  Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506
• 3. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 4. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 5. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245

Recent Advances in the Study of 2-Hydroxy-4-methylpentanenitrile (CAS: 54129-53-2) and Its Applications in Chemical Biology and Pharmaceutical Research

The compound 2-Hydroxy-4-methylpentanenitrile (CAS: 54129-53-2) has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This nitrile derivative, characterized by its hydroxyl and methyl functional groups, serves as a key intermediate in the synthesis of various bioactive molecules. Recent studies have explored its potential in drug discovery, metabolic pathway modulation, and as a building block for complex organic frameworks. This research brief aims to synthesize the latest findings and highlight the compound's emerging roles in the field.

One of the most notable advancements involves the use of 2-Hydroxy-4-methylpentanenitrile in the development of enzyme inhibitors. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its efficacy as a precursor in the synthesis of selective serine hydrolase inhibitors, which show promise in treating neurodegenerative diseases. The study utilized a combination of computational docking and kinetic assays to validate the compound's binding affinity and inhibitory potential, paving the way for further optimization of related drug candidates.

In addition to its pharmacological applications, recent research has also focused on the compound's role in asymmetric synthesis. A team from the University of Tokyo reported a novel catalytic system that leverages 2-Hydroxy-4-methylpentanenitrile to achieve high enantioselectivity in the production of chiral alcohols, a critical step in the manufacture of many pharmaceuticals. The study, published in ACS Catalysis, highlighted the compound's stability under mild reaction conditions and its compatibility with a range of transition metal catalysts.

Another area of interest is the compound's metabolic fate in biological systems. A 2024 paper in Chemical Research in Toxicology investigated the biotransformation pathways of 2-Hydroxy-4-methylpentanenitrile in mammalian liver microsomes. The findings revealed that the compound undergoes rapid oxidation to form corresponding aldehydes and carboxylic acids, which may have implications for its pharmacokinetic profile and toxicity. These insights are crucial for assessing the safety and efficacy of derivatives in preclinical development.

Looking ahead, researchers are exploring the potential of 2-Hydroxy-4-methylpentanenitrile in targeted drug delivery systems. Preliminary data from a collaborative study between MIT and Pfizer suggest that the compound's hydroxyl group can be functionalized to attach payloads such as anticancer agents, enabling site-specific release. This approach, detailed in a recent Nature Communications article, could minimize off-target effects and improve therapeutic outcomes in oncology applications.

In conclusion, the growing body of research on 2-Hydroxy-4-methylpentanenitrile (CAS: 54129-53-2) underscores its multifaceted utility in chemical biology and drug development. From enzyme inhibition to asymmetric synthesis and metabolic studies, the compound continues to reveal new opportunities for innovation. As methodologies advance and interdisciplinary collaborations flourish, we anticipate even more groundbreaking discoveries involving this versatile molecule in the coming years.

• 110792-88-6(Hexanenitrile, 2-hydroxy-2,5-dimethyl-)
• 4111-12-0(2-hydroxy-2-methyl-hexanenitrile)
• 174849-23-1((S)-2-hydroxy-2,4-dimethyl-pentanenitrile)
• 4354-47-6(Cyclohexaneacetonitrile, a-hydroxy-)
• 49685-67-8
• 135362-75-3((R)-2-hydroxy-2-methyl-heptanenitrile)
• 135415-89-3((R)-2-hydroxy-2-methyl-hexanenitrile)
• 882-83-7(Cyclododecanecarbonitrile, 1-hydroxy-)
• 110905-95-8(Pentanenitrile, 2-hydroxy-4-methyl-, (R)-)
• 63834-28-6(2-hydroxy-4,6,6-trimethylheptanenitrile)